Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-13-0639
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)